WCM Investment Management
INSM icon

WCM Investment Management’s Insmed INSM Stock Holding History

WCM Investment Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Buy
19,033
+3,326
+21% +$403K ﹤0.01% 204
2026
Q1 		$2.41M Buy
15,707
+5,339
+51% +$821K 0.01% 207
2025
Q4 		$1.8M Sell
10,368
-5,132
-33% -$936K ﹤0.01% 207
2025
Q3 		$2.2M Sell
15,500
-138,486
-90% -$17M ﹤0.01% 198
2025
Q2 		$15.3M Buy
153,986
+9,607
+7% +$735K 0.04% 122
2025
Q1 		$11.3M Sell
144,379
-361
-0.2% -$27.6K 0.03% 135
2024
Q4 		$9.97M Sell
144,740
-3,590
-2% -$259K 0.02% 155
2024
Q3 		$10.8M Buy
148,330
+54,806
+59% +$4.04M 0.02% 145
2024
Q2 		$6.26M Sell
93,524
-226,477
-71% -$8.78M 0.01% 157
2024
Q1 		$8.68M Buy
320,001
+24,673
+8% +$691K 0.02% 146
2023
Q4 		$9.37M Buy
295,328
+5,592
+2% +$145K 0.03% 143
2023
Q3 		$7.32M Buy
289,736
+5,115
+2% +$117K 0.02% 141
2023
Q2 		$5.99M Buy
284,621
+25,097
+10% +$476K 0.02% 149
2023
Q1 		$4.42M Sell
259,524
-187
-0.1% -$3.63K 0.01% 158
2022
Q4 		$5.19M Sell
259,711
-3,595
-1% -$69.5K 0.02% 157
2022
Q3 		$5.76M Buy
263,306
+12,057
+5% +$289K 0.02% 146
2022
Q2 		$5.04M Sell
251,249
-393
-0.2% -$8.23K 0.02% 147
2022
Q1 		$5.91M Buy
251,642
+9,467
+4% +$220K 0.02% 141
2021
Q4 		$6.6M Buy
242,175
+16,360
+7% +$468K 0.01% 146
2021
Q3 		$6.22M Buy
225,815
+66,316
+42% +$1.74M 0.01% 144
2021
Q2 		$4.54M Buy
159,499
+6,350
+4% +$188K 0.01% 140
2021
Q1 		$5.22M Sell
153,149
-2,930
-2% -$112K 0.01% 137
2020
Q4 		$5.2M Buy
156,079
+499
+0.3% +$18.2K 0.01% 144
2020
Q3 		$5M Buy
155,580
+9,309
+6% +$268K 0.02% 135
2020
Q2 		$4.03M Buy
146,271
+45,211
+45% +$1.07M 0.02% 138
2020
Q1 		$1.62M Buy
+101,060
New +$2.4M 0.01% 153

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

WCM Investment Management's INSM Position: Q2 2026 in Review

WCM Investment Management increased its Insmed (INSM) stake by 21% in Q2 2026, buying an estimated $403K and bringing the position to 19,033 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #204.

WCM Investment Management first reported a position in INSM in Q1 2020 and has held it in 26 quarters since. The position peaked at $15.3M in Q2 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • WCM Investment Management held 19,033 shares of Insmed worth $1.99M as of Q2 2026.
  • WCM Investment Management bought 3,326 Insmed shares in Q2 2026, an estimated $403K.
  • Insmed made up ﹤0.01% of WCM Investment Management's portfolio in Q2 2026, its #204 holding.
  • WCM Investment Management first reported a position in Insmed in Q1 2020 and has held it in 26 quarters since.
  • WCM Investment Management's Insmed position peaked at $15.3M in Q2 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on WCM Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.